Skip to main content

Advertisement

SpringerLink
Log in

Cardiovascular disease in patients with autoinflammatory syndromes

  • Comorbidities
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Autoinflammatory syndromes (AIS) are characterized by recurring events of inflammation, leading to a variety of organ manifestations and fever attacks. A subgroup of AIS is commonly referred to as hereditary periodic fever syndromes (HPFS). There is substantial evidence that autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus are strongly associated with cardiovascular morbidity and mortality. The link between AIS and cardiovascular disease is not that clear, even if the concept of continuous inflammation as a risk factor for cardiovascular disease is widely accepted. Research on the association of AIS and cardiovascular disease is increasing within the last years. In this review, we will discuss the association of several AIS with cardiovascular disease. Based on the rarity of some entities, lack of data, however, led to exclusion of some rare AIS. Especially, for Behcet’s disease (BD), adult-onset Still’s disease (AOSD), and Familial Mediterranean fever (FMF), there is an association with a number of cardiovascular abnormalities. BD is the AIS, which is most strongly associated with manifestation in the arterial and venous system. AOSD is strongly associated with cardiac inflammation (peri-/myocarditis). FMF patients are likely to suffer from serositis. Of note, there seems to be a link between variants of AOSD as well as FMF and idiopathic recurrent acute pericarditis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Masters SL, Simon A, Aksentijevich I, Kastner DL (2009) Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 27:621–668. doi:10.1146/annurev.immunol.25.022106.141627

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Samuels J, Ozen S (2006) Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol 18:108–117. doi:10.1097/01.bor.0000198006.65697.5b

    Article  PubMed  Google Scholar 

  3. Ozkurede VU, Franchi L (2012) Immunology in clinic review series; focus on autoinflammatory diseases: role of inflammasomes in autoinflammatory syndromes. Clin Exp Immunol 167:382–390. doi:10.1111/j.1365-2249.2011.04535.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Touzot M, Cacoub P, Bodaghi B et al (2014) IFN-α induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease. Autoimmun Rev. doi:10.1016/j.autrev.2014.12.009

    PubMed  Google Scholar 

  5. Gerfaud-Valentin M, Jamilloux Y, Iwaz J, Sève P (2014) Adult-onset Still’s disease. Autoimmun Rev 13:708–722. doi:10.1016/j.autrev.2014.01.058

    Article  CAS  PubMed  Google Scholar 

  6. McDermott MF, Aksentijevich I (2002) The autoinflammatory syndromes. Curr Opin Allergy Clin Immunol 2:511–516. doi:10.1097/01.all.0000044536.45448.2d

    Article  PubMed  Google Scholar 

  7. Autoinflammatory alliance: systemic autoinflammatory diseases (SAID) database. http://www.autoinflammatory-search.org/diseases. Accessed 2 Apr 2017

  8. Hausmann JS, Dedeoglu F (2013) Autoinflammatory diseases in pediatrics. Dermatol Clin 31:481–494. doi:10.1016/j.det.2013.04.003

    Article  CAS  PubMed  Google Scholar 

  9. Ciccarelli F, De Martinis M, Ginaldi L (2013) An update on autoinflammatory diseases. Curr Med Chem 21:261–269. doi:10.2174/09298673113206660303

    Article  PubMed Central  CAS  Google Scholar 

  10. Behçet H (1937) Über rezidivierende, aphtöse, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105:1152–1163

    Google Scholar 

  11. Thomas EWP (1947) So-called triple-symptom complex of Behçet. Br Med J 1:14–16

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Davatchi F, Assaad-Khalil S, Calamia KT et al (2014) The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28:338–347. doi:10.1111/jdv.12107

    Article  Google Scholar 

  13. Maldini C, LaValley MP, Cheminant M et al (2012) Relationships of HLA-B51 or B5 genotype with Behçet’s disease clinical characteristics: systematic review and meta-analyses of observational studies. Rheumatology 51:887–900. doi:10.1093/rheumatology/ker428

    Article  PubMed  Google Scholar 

  14. Lu X (2017) The impact of IL-17 in atherosclerosis. Curr Med Chem. doi:10.2174/0929867324666170419150614

    Google Scholar 

  15. Sari RA, Kiziltunç A, Tays’y S et al (2005) Levels of soluble E-selectin in patients with active Behçet’s disease. Clin Rheumatol 24:55–59. doi:10.1007/s10067-004-0982-8

    Article  Google Scholar 

  16. Emmi G, Silvestri E, Squatrito D et al (2014) Behçet’s syndrome pathophysiology and potential therapeutic targets. Intern Emerg Med 9:257–265. doi:10.1007/s11739-013-1036-5

    Article  PubMed  Google Scholar 

  17. Turkoz Y, Evereklioglu C, Özkiriş A et al (2005) Serum levels of soluble P-selectin are increased and associated with disease activity in patients with Behçet’s syndrome. Mediat Inflamm 2005:237–241. doi:10.1155/MI.2005.237

    Article  CAS  Google Scholar 

  18. Fernández-Bello I, López-Longo FJ, Arias-Salgado EG et al (2013) Behçet’s disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity. Orphanet J Rare Dis 8:81. doi:10.1186/1750-1172-8-81

    Article  PubMed  PubMed Central  Google Scholar 

  19. Kayatas K, Karatoprak C, Cebeci F et al (2013) Presence of low lipid levels in patients with Behçet’s disease as a protector against atherosclerosis. Eur Rev Med Pharmacol Sci 17:2330–2334

    CAS  PubMed  Google Scholar 

  20. Caldas CAM, Borba EF, Bortolotto LA et al (2013) Increased arterial stiffness assessed by pulse wave velocity in Behçet’s disease and its association with the lipid profile. J Eur Acad Dermatol Venereol 27:454–459. doi:10.1111/j.1468-3083.2012.04458.x

    Article  CAS  PubMed  Google Scholar 

  21. La Regina M, Gasparyan AY, Orlandini F, Prisco D (2010) Behçet’s disease as a model of venous thrombosis. Open Cardiovasc Med J 4:71–77. doi:10.2174/1874192401004020071

    PubMed  PubMed Central  Google Scholar 

  22. Gasparyan AY, Ayvazyan L, Pretorius E, Kitas GD (2014) Platelets in rheumatic diseases: friend or foe? Curr Pharm Des 20:552–566

    Article  CAS  PubMed  Google Scholar 

  23. Davatchi F, Chams-Davatchi C, Shams H et al (2016) Adult Behçet’s disease in Iran: analysis of 6075 patients. Int J Rheum Dis 19:95–103. doi:10.1111/1756-185X.12691

    Article  CAS  PubMed  Google Scholar 

  24. Tascilar K, Melikoglu M, Ugurlu S et al (2014) Vascular involvement in Behçet’s syndrome: a retrospective analysis of associations and the time course. Rheumatology 53:2018–2022. doi:10.1093/rheumatology/keu233

    Article  CAS  PubMed  Google Scholar 

  25. Seyahi E, Yurdakul S (2011) Behçet’s syndrome and thrombosis. Mediterr J Hematol Infect Dis. doi:10.4084/MJHID.2011.026

    PubMed  PubMed Central  Google Scholar 

  26. Ugurlu N, Bozkurt S, Bacanli A et al (2015) The natural course and factors affecting severity of Behçet’s disease: a single-center cohort of 368 patients. Rheumatol Int 35:2103–2107. doi:10.1007/s00296-015-3310-5

    Article  PubMed  Google Scholar 

  27. Tohmé A, Aoun N, El-Rassi B, Ghayad E (2003) Vascular manifestations of Behçet’s disease. Eighteen cases among 140 patients. Joint Bone Spine 70:384–389. doi:10.1016/S1297-319X(03)00076-9

    Article  PubMed  Google Scholar 

  28. Wu X, Li G, Huang X et al (2014) Behçet’s disease complicated with thrombosis: a report of 93 Chinese cases. Medicine (Baltim) 93:e263. doi:10.1097/MD.0000000000000263

    Article  Google Scholar 

  29. Tunc R, Keyman E, Melikoglu M et al (2002) Target organ associations in Turkish patients with Behçet’s disease: a cross sectional study by exploratory factor analysis. J Rheumatol 29(11):2393–2396

    PubMed  Google Scholar 

  30. Seyahi E, Cakmak OS, Tutar B et al (2015) Clinical and ultrasonographic evaluation of lower-extremity vein thrombosis in Behçet syndrome: an observational study. Medicine (Baltim) 94:e1899. doi:10.1097/MD.0000000000001899

    Article  Google Scholar 

  31. Alibaz-Oner F, Karadeniz A, Yılmaz S et al (2015) Behçet disease with vascular involvement effects of different therapeutic regimens on the incidence of new relapses. Medicine. doi:10.1097/MD.0000000000000494

    PubMed  PubMed Central  Google Scholar 

  32. Seyahi E (2016) Behçet’s disease: how to diagnose and treat vascular involvement. Best Pract Res Clin Rheumatol 30:279–295. doi:10.1016/j.berh.2016.08.002

    Article  PubMed  Google Scholar 

  33. Desbois AC, Wechsler B, Resche-Rigon M et al (2012) Immunosuppressants reduce venous thrombosis relapse in Behçet’s disease. Arthritis Rheum 64:2753–2760. doi:10.1002/art.34450

    Article  CAS  PubMed  Google Scholar 

  34. Mehta P, Laffan M, Haskard DO (2010) Thrombosis and Behçet’s syndrome in non-endemic regions. Rheumatology 49:2003–2004. doi:10.1093/rheumatology/keq090

    Article  PubMed  Google Scholar 

  35. Sarica-Kucukoglu R, Akdag-Kose A, Kayabalı M et al (2006) Vascular involvement in Behçet’s disease: a retrospective analysis of 2319 cases. Int J Dermatol 45:919–921. doi:10.1111/j.1365-4632.2006.02832.x

    Article  PubMed  Google Scholar 

  36. Yazici H, Seyahi E (2016) Behçet syndrome: the vascular cluster. Turk J Med Sci 46:1277–1280. doi:10.3906/sag-1605-28

    Article  PubMed  Google Scholar 

  37. Uskudar O, Akdogan M, Sasmaz N et al (2008) Etiology and portal vein thrombosis in Budd–Chiari syndrome. World J Gastroenterol 14:2858–2862

    Article  PubMed  PubMed Central  Google Scholar 

  38. Valla D-C (2009) Primary Budd–Chiari syndrome. J Hepatol 50:195–203. doi:10.1016/j.jhep.2008.10.007

    Article  PubMed  Google Scholar 

  39. Denninger M-H, Chaït Y, Casadevall N et al (2000) Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31:587–591. doi:10.1002/hep.510310307

    Article  CAS  PubMed  Google Scholar 

  40. Shin N, Kim YH, Xu H et al (2016) Redefining Budd–Chiari syndrome: a systematic review. World J Hepatol 8:691–702. doi:10.4254/wjh.v8.i16.691

    Article  PubMed  PubMed Central  Google Scholar 

  41. Desbois AC, Rautou PE, Biard L et al (2014) Behçet’s disease in Budd–Chiari syndrome. Orphanet J Rare Dis 9:104. doi:10.1186/s13023-014-0153-1

    Article  PubMed  PubMed Central  Google Scholar 

  42. Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M (1997) Budd–Chiari syndrome: a common complication of Behçet’s disease. Am J Gastroenterol 92:858–862

    CAS  PubMed  Google Scholar 

  43. Seyahi E (2016) Behçet’s disease: How to diagnose and treat vascular involvement. Best Pract Res Clin Rheumatol. doi:10.1016/j.berh.2016.08.002

    PubMed  Google Scholar 

  44. Aguiar de Sousa D, Mestre T, Ferro JM (2011) Cerebral venous thrombosis in Behçet’s disease: a systematic review. J Neurol 258:719–727. doi:10.1007/s00415-010-5885-9

    Article  CAS  PubMed  Google Scholar 

  45. Bousser M-G, Ferro JM (2007) Cerebral venous thrombosis: an update. Lancet Neurol 6:162–170. doi:10.1016/S1474-4422(07)70029-7

    Article  CAS  PubMed  Google Scholar 

  46. Akman-Demir G, Serdaroglu P, Tasçi B (1999) Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. Brain 122:2171–2182. doi:10.1093/brain/122.11.2171

    Article  PubMed  Google Scholar 

  47. Hamuryudan V, Er T, Seyahi E et al (2004) Pulmonary artery aneurysms in Behçet syndrome. Am J Med 117:867–870. doi:10.1016/j.amjmed.2004.05.027

    Article  PubMed  Google Scholar 

  48. Erkan F, Kiyan E, Tunaci A (2002) Pulmonary complications of Behçet’s disease. Clin Chest Med 23:493–503

    Article  PubMed  Google Scholar 

  49. Alpagut U, Ugurlucan M, Dayıoglu E (2007) Major arterial involvement and review of Behçet’s disease. Ann Vasc Surg 21:232–239. doi:10.1016/j.avsg.2006.12.004

    Article  PubMed  Google Scholar 

  50. Cocco G, Gasparyan AY (2010) Behçet’s disease: an insight from a cardiologist’s point of view. Open Cardiovasc Med J 4:63–70. doi:10.2174/1874192401004020063

    PubMed  PubMed Central  Google Scholar 

  51. Seyahi E, Melikoglu M, Akman C et al (2012) Pulmonary artery involvement and associated lung disease in Behçet disease. Medicine (Baltim) 91:35–48. doi:10.1097/MD.0b013e318242ff37

    Article  Google Scholar 

  52. Hamuryudan V, Seyahi E, Ugurlu S et al (2015) Pulmonary artery involvement in Behçet’s syndrome: effects of anti-Tnf treatment. Semin Arthritis Rheum 45:369–373. doi:10.1016/j.semarthrit.2015.06.008

    Article  CAS  PubMed  Google Scholar 

  53. Bruno RM, Bianchini E, Faita F et al (2014) Intima media thickness, pulse wave velocity, and flow mediated dilation. Cardiovasc Ultrasound 12:34. doi:10.1186/1476-7120-12-34

    Article  PubMed  PubMed Central  Google Scholar 

  54. Kocabay G, Hasdemir H, Yildiz M (2012) Evaluation of pulse wave velocity in systemic lupus erythematosus, rheumatoid arthritis and Behçet’s disease. J Cardiol 59:72–77. doi:10.1016/j.jjcc.2011.09.004

    Article  PubMed  Google Scholar 

  55. Yıldırım A, Karakaş MS, Kılınç AY et al (2016) Evaluation of arterial stiffness and subclinical atherosclerosis in patients with Behçet’s disease without cardiovascular involvement. Turk Kardiyol Dern Ars 44:575–581

    PubMed  Google Scholar 

  56. Kürüm T, Yildiz M, Soy M et al (2005) Arterial distensibility as determined by carotid-femoral pulse wave velocity in patients with Behçet’s disease. Clin Rheumatol 24:134–138. doi:10.1007/s10067-004-0990-8

    Article  PubMed  Google Scholar 

  57. Merashli M, Ster IC, Richard P, Ames J (2016) Subclinical atherosclerosis in Behçet’s disease: a systematic review and meta-analysis. Semin Arthritis Rheum 45:502–510. doi:10.1016/j.semarthrit.2015.06.018

    Article  PubMed  Google Scholar 

  58. Ozturk C, Balta S, Balta I et al (2015) Neutrophil-lymphocyte ratio and carotid-intima media thickness in patients with Behçet disease without cardiovascular involvement. Angiology 66:291–296. doi:10.1177/0003319714527638

    Article  PubMed  Google Scholar 

  59. Yuksel M, Yildiz A, Oylumlu M et al (2016) Novel markers of endothelial dysfunction and inflammation in Behçet’s disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio. Clin Rheumatol 35:701–708. doi:10.1007/s10067-015-2907-0

    Article  PubMed  Google Scholar 

  60. Uyar B, Uyar B, Solak A et al (2015) Evaluation of arterial stiffness in patients with behçet’s disease by using noninvasive radiological methods such as intima-media thickness of the carotid, ankle-brachial pressure index, coronary artery calcium scoring, and their relation to serum fetuin-a levels: a case-control study. Ann Dermatol. doi:10.5021/ad.2015.27.6.702

    PubMed  PubMed Central  Google Scholar 

  61. Cekmen M, Evereklioglu C, Er H et al (2003) Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet’s syndrome. Int J Dermatol 42:870–875

    Article  CAS  PubMed  Google Scholar 

  62. Farouk H, Zayed HS, El-Chilali K (2016) Cardiac findings in patients with Behçet’s disease: facts and controversies. Anatol J Cardiol 16:529–533. doi:10.14744/AnatolJCardiol.2016.7029

    PubMed  PubMed Central  Google Scholar 

  63. Jin SJ, Mun H-S, Chung S-J et al (2008) Acute myocardial infarction due to sinus of Valsalva aneurysm in a patient with Behçet’s disease. Clin Exp Rheumatol 26:S117–S120

    CAS  PubMed  Google Scholar 

  64. Ayari J, Mourali M, Farhati A, Mechmeche R (2014) Left main coronary artery thrombosis revealing angio-Behçet syndrome. Egypt J Intern Med 26:88. doi:10.4103/1110-7782.139578

    Article  PubMed  PubMed Central  Google Scholar 

  65. Zhuang J, Wang S, Zhang Z et al (2008) Acute myocardial infarction and ascending aortic aneurysm in a child with Behçet's disease. Turk J Pediatr 50(1):81–85

    PubMed  Google Scholar 

  66. Comarmond C, Cacoub P (2017) Myocarditis in auto-immune or auto-inflammatory diseases. Autoimmun Rev 16(8):811–816. doi:10.1016/j.autrev.2017.05.021

    Article  CAS  PubMed  Google Scholar 

  67. Aslam F, Bandeali SJ, Crowson C, Alam M (2016) Cardiac function and diastolic dysfunction in behçet’s disease: a systematic review and meta-analysis. Int J Rheumatol 2016:1–11. doi:10.1155/2016/9837184

    Article  Google Scholar 

  68. Leiba M, Seligsohn U, Sidi Y et al (2004) Thrombophilic factors are not the leading cause of thrombosis in Behçet’s disease. Ann Rheum Dis 63:1445–1449. doi:10.1136/ard.2003.014241

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Chamorro A-J, Marcos M, Hernández-García I et al (2013) Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behçet’s disease: a systematic review and meta-analysis. Autoimmun Rev 12:607–616. doi:10.1016/j.autrev.2012.11.001

    Article  CAS  PubMed  Google Scholar 

  70. Tayer-Shifman OE, Seyahi E, Nowatzky J, Ben-Chetrit E (2012) Major vessel thrombosis in Behçet’s disease: the dilemma of anticoagulant therapy—the approach of rheumatologists from different countries. Clin Exp Rheumatol 30:735–740

    PubMed  Google Scholar 

  71. Hatemi G, Silman A, Bang D et al (2008) EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 67:1656–1662. doi:10.1136/ard.2007.080432

    Article  CAS  PubMed  Google Scholar 

  72. Seyahi E, Yazici H (2016) To anticoagulate or not to anticoagulate vascular thrombosis in Behçet’s syndrome: an enduring question. Clin Exp Rheumatol 34:S3–S4

    PubMed  Google Scholar 

  73. Saenz A, Ausejo M, Shea B, et al (1998) Pharmacotherapy for Behçet’s syndrome. In: Shea B (ed) Cochrane Database Syst. Rev. Wiley, Chichester, p CD001084

  74. Hatemi G, Silman A, Bang D et al (2009) Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis 68:1528–1534. doi:10.1136/ard.2008.087957

    Article  CAS  PubMed  Google Scholar 

  75. Vallet H, Riviere S, Sanna A et al (2015) Efficacy of anti-TNF alpha in severe and/or refractory Behçet’s disease: multicenter study of 124 patients. J Autoimmun 62:67–74. doi:10.1016/j.jaut.2015.06.005

    Article  CAS  PubMed  Google Scholar 

  76. Seyahi E, Hamuryudan V, Hatemi G et al (2007) Infliximab in the treatment of hepatic vein thrombosis (Budd–Chiari syndrome) in three patients with Behçet’s syndrome. Rheumatology 46:1213–1214. doi:10.1093/rheumatology/kem103

    Article  CAS  PubMed  Google Scholar 

  77. Hamuryudan V, Ozyazgan Y, Hizli N et al (1997) Azathioprine in Behçet’s syndrome: effects on long-term prognosis. Arthritis Rheum 40:769–774. doi:10.1002/1529-0131(199704)40:4<769:AID-ART24>3.0.CO;2-E

    Article  CAS  PubMed  Google Scholar 

  78. Mirouse A, Barete S, Monfort J-B et al (2017) Ustekinumab for Behçet’s disease. J Autoimmun. doi:10.1016/j.jaut.2017.05.002

    PubMed  Google Scholar 

  79. Kilic A, Varkal MA, Durmus MS et al (2015) Relationship between clinical findings and genetic mutations in patients with familial Mediterranean fever. Pediatr Rheumatol 13:59. doi:10.1186/s12969-015-0057-1

    Article  Google Scholar 

  80. Kees S, Langevitz P, Zemer D et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 90:1879–1885. doi:10.1002/1529-0131(199710)40:10<1879:AID-ART23>3.0.CO;2-M

    Google Scholar 

  81. Zizzo C, Colomba P, Albeggiani G et al (2013) Misdiagnosis of familial Mediterranean fever in patients with Anderson–Fabry disease. Clin Genet 83:576–581. doi:10.1111/j.1399-0004.2012.01940.x

    Article  CAS  PubMed  Google Scholar 

  82. French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31. doi:10.1038/ng0997-25

    Article  Google Scholar 

  83. The International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 90:797–807. doi:10.1016/S0092-8674(00)80539-5

    Article  Google Scholar 

  84. Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever. Am J Med 43:227–253. doi:10.1016/0002-9343(67)90167-2

    Article  CAS  PubMed  Google Scholar 

  85. Özçakar ZB, YalçInkaya F (2011) Vascular comorbidities in familial Mediterranean fever. Rheumatol Int 31:1275–1281. doi:10.1007/s00296-011-1845-7

    Article  PubMed  Google Scholar 

  86. Cantarini L, Lopalco G, Selmi C et al (2015) Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis. Autoimmun Rev 14:90–97. doi:10.1016/j.autrev.2014.10.005

    Article  CAS  PubMed  Google Scholar 

  87. Hermansson C, Lundqvist A, Wasslavik C et al (2013) Reduced expression of NLRP3 and MEFV in human ischemic heart tissue. Biochem Biophys Res Commun 430:425–428. doi:10.1016/j.bbrc.2012.11.070

    Article  CAS  PubMed  Google Scholar 

  88. Korkmaz C, Ozdogan H, Kasapçopur O, Yazici H (2002) Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61:79–81. doi:10.1136/ard.61.1.79

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Ben-Zvi I, Livneh A (2011) Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol 7:105–112. doi:10.1038/nrrheum.2010.181

    Article  CAS  PubMed  Google Scholar 

  90. Rigante D, Cantarini L, Imazio M et al (2011) Autoinflammatory diseases and cardiovascular manifestations. Ann Med 43:341–346. doi:10.3109/07853890.2010.547212

    Article  CAS  PubMed  Google Scholar 

  91. Lange-Sperandio B, Möhring K, Gutzler F, Mehls O (2004) Variable expression of vasculitis in siblings with familial Mediterranean fever. Pediatr Nephrol 19:539–543. doi:10.1007/s00467-004-1440-1

    Article  PubMed  Google Scholar 

  92. Sarı İ, Birlik M, Kasifoğlu T (2014) Familial Mediterranean fever: an updated review. Eur J Rheumatol 1:21–33. doi:10.5152/eurjrheum.2014.006

    Article  PubMed  PubMed Central  Google Scholar 

  93. Suner A, Kaya H, Koronulllu S et al (2013) Heart rate variability in familial mediterranean fever patients. Int J Cardiol 163:S200

    Article  Google Scholar 

  94. Canpolat U, Dural M, Aytemir K et al (2012) Evaluation of various cardiac autonomic indices in patients with familial Mediterranean fever on colchicine treatment. Auton Neurosci 167:70–74. doi:10.1016/j.autneu.2011.11.001

    Article  PubMed  Google Scholar 

  95. Rozenbaum M, Naschitz JE, Yudashkin M et al (2004) Cardiovascular reactivity score for the assessment of dysautonomia in familial Mediterranean fever. Rheumatol Int 24:147–152. doi:10.1007/s00296-003-0344-x

    Article  PubMed  Google Scholar 

  96. Ugurlu S, Seyahi E, Cetinkaya F et al (2009) Intima-media thickening in patients with familial Mediterranean fever. Rheumatology 48:911–915. doi:10.1093/rheumatology/kep131

    Article  PubMed  Google Scholar 

  97. Bilginer Y, Ozaltin F, Basaran C et al (2008) Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis. Rheumatol Int 28:1211–1216. doi:10.1007/s00296-008-0605-9

    Article  CAS  PubMed  Google Scholar 

  98. Peru H, Altun B, Doǧan M et al (2008) The evaluation of carotid intima-media thickness in children with familial Mediterranean fever. Clin Rheumatol 27:689–694. doi:10.1007/s10067-007-0764-1

    Article  PubMed  Google Scholar 

  99. Yildiz M, Masatlioglu S, Seymen P et al (2006) The carotid-femoral (aortic) pulse wave velocity as a marker of arterial stiffness in familial Mediterranean fever. Can J Cardiol 22:1127–1131

    Article  PubMed  PubMed Central  Google Scholar 

  100. Karakurt Ariturk O, Ureten K, Sari M et al (2013) Relationship of paraoxonase-1, malondialdehyde and mean platelet volume with markers of atherosclerosis in familial Mediterranean fever: an observational study. Anadolu Kardiyol Derg 13(4):357–362. doi:10.5152/akd.2013.103

    PubMed  Google Scholar 

  101. Kucuk A, Uslu AU, Arslan S et al (2016) Ischemia-modified albumin and atherosclerosis in patients with familial Mediterranean fever. Angiology 67:456–460. doi:10.1177/0003319715595744

    Article  CAS  PubMed  Google Scholar 

  102. Acay A, Ulu MS, Ahsen A et al (2014) Atherogenic index as a predictor of atherosclerosis in subjects with familial Mediterranean fever. Medicina (Kaunas) 50:329–333. doi:10.1016/j.medici.2014.11.009

    Article  Google Scholar 

  103. Twig G, Livneh A, Vivante A et al (2014) Cardiovascular and metabolic risk factors in inherited auto inflammation. J Clin Endocrinol Metab 99:E2123–E2128. doi:10.1210/jc.2014-2096

    Article  CAS  PubMed  Google Scholar 

  104. Ceylan O, Ozgur S, Orun UA et al (2015) Assessment of left ventricular functions with tissue Doppler, strain, and strain rate echocardiography in patients with familial Mediterranean fever. Anatol J Cardiol 15:663–668. doi:10.5152/akd.2014.5544

    Article  PubMed  Google Scholar 

  105. Sari I, Arican Ö, Can G et al (2008) Assessment of aortic stiffness and ventricular functions in familial Mediterranean fever. Anadolu Kardiyol Derg 8:271–278

    PubMed  Google Scholar 

  106. Kalkan GY, Bayram NA, Erten S et al (2010) Evaluation of left ventricle function by strain imaging in patients with familial Mediterranean fever. Echocardiography 27:1056–1060. doi:10.1111/j.1540-8175.2010.01217.x

    Article  PubMed  Google Scholar 

  107. Baysal T, Peru H, Oran B et al (2009) Left ventricular diastolic function evaluated with tissue Doppler imaging in children with familial Mediterranean fever. Clin Rheumatol 28:23–28. doi:10.1007/s10067-008-0976-z

    Article  PubMed  Google Scholar 

  108. Tavil Y, Ureten K, Oztürk MA et al (2008) The detailed assessment of left and right ventricular functions by tissue Doppler imaging in patients with familial Mediterranean fever. Clin Rheumatol 27:189–194. doi:10.1007/s10067-007-0676-0

    Article  PubMed  Google Scholar 

  109. Ozdemir O, Agras PI, Aydin Y et al (2012) Assessment of cardiac functions using tissue Doppler imaging in children with familial Mediterranean fever. Cardiol Young 22:188–193. doi:10.1017/S1047951111001168

    Article  PubMed  Google Scholar 

  110. Nussinovitch U, Livneh A, Volovitz B et al (2012) Normal QT dispersion in colchicine-resistant familial Mediterranean fever (FMF). Clin Rheumatol 31:1093–1096. doi:10.1007/s10067-012-1982-8

    Article  PubMed  Google Scholar 

  111. Nussinovitch U, Kaminer K, Nussinovitch M et al (2012) QT interval variability in familial Mediterranean fever: a study in colchicine-responsive and colchicine-resistant patients. Clin Rheumatol 31:795–799. doi:10.1007/s10067-011-1926-8

    Article  PubMed  Google Scholar 

  112. Nussinovitch N, Livneh A, Katz K et al (2010) QT dispersion in uncomplicated familial Mediterranean fever. Clin Rheumatol 29:1353–1356. doi:10.1007/s10067-010-1434-2

    Article  PubMed  Google Scholar 

  113. Kirbas A, Daglar K, Kirbas O et al (2016) P wave and QT dispersion in familial mediterranean fever. Eur Rev Med Pharmacol Sci 20:3427–3433

    CAS  PubMed  Google Scholar 

  114. Koca B, Kasapçopur O, Bakari S et al (2012) QT dispersion and cardiac involvement in children with Familial Mediterranean fever. Cardiol Young 22:404–409. doi:10.1017/S1047951111001867

    Article  PubMed  Google Scholar 

  115. Topal F, Tanindi A, Kurtoglu H et al (2011) QT dispersion is not increased in familial mediterranean fever. J Int Med Res 39:2006–2011. doi:10.1177/147323001103900547

    Article  CAS  PubMed  Google Scholar 

  116. Nussinovitch U, Nussinovitch N, Nussinovitch M et al (2012) QT dispersion in amyloidosis due to familial Mediterranean fever. Rheumatol Int 32:1945–1948. doi:10.1007/s00296-011-1896-9

    Article  PubMed  Google Scholar 

  117. Nussinovitch U, Livneh A, Nussinovitch M et al (2011) P-wave dispersion in systemic AA amyloidosis of familial Mediterranean fever. Clin Rheumatol 30:1295–1298. doi:10.1007/s10067-011-1745-y

    Article  PubMed  Google Scholar 

  118. Nussinovitch N, Livneh A, Katz K et al (2011) P wave dispersion in familial Mediterranean fever. Rheumatol Int 31:1591–1594. doi:10.1007/s00296-010-1508-0

    Article  PubMed  Google Scholar 

  119. Acar G, Akcay A, Sayarlioglu M et al (2009) Assessment of atrial conduction time in patients with familial mediterranean fever. PACE Pacing Clin Electrophysiol 32:308–313

    Article  PubMed  Google Scholar 

  120. Akcay A, Acar G, Sayarlioglu M et al (2009) QT dispersion and transmural dispersion of repolarization in patients with familial Mediterranean fever. Mod Rheumatol 19:550–555. doi:10.1007/s10165-009-0196-7

    Article  PubMed  Google Scholar 

  121. Celik MM, Buyukkaya E, Ustun N et al (2015) Relation of fragmented QRS to tissue Doppler-derived parametersin patients with familial Mediterranean fever. Wien Klin Wochenschr 127:185–190. doi:10.1007/s00508-015-0714-x

    Article  PubMed  Google Scholar 

  122. Ahbap E, Sakaci T, Kara E et al (2015) Familial Mediterranean Fever is associated with abnormal ventricular repolarization indices. Rev Med Chil 143:1560–1568. doi:10.4067/S0034-98872015001200009

    Article  PubMed  Google Scholar 

  123. Caliskan M, Gullu H, Yilmaz S et al (2007) Impaired coronary microvascular function in familial Mediterranean fever. Atherosclerosis 195:e161–e167. doi:10.1016/j.atherosclerosis.2007.06.014

    Article  CAS  PubMed  Google Scholar 

  124. Sakallı H, Kal O (2013) Mean platelet volume as a potential predictor of proteinuria and amyloidosis in familial Mediterranean fever. Clin Rheumatol 32:1185–1190. doi:10.1007/s10067-013-2257-8

    Article  PubMed  Google Scholar 

  125. Kees S, Langevitz P, Zemer D et al (1997) Attacks of pericarditis as a manifestation of familial Mediterranean fever (FMF). QJM 90:643–647

    Article  CAS  PubMed  Google Scholar 

  126. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD (2011) Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 17:47–58

    Article  CAS  PubMed  Google Scholar 

  127. Terekeci HM, Ulusoy ER, Kucukarslan NM et al (2008) Familial Mediterranean fever attacks do not alter functional and morphologic tissue Doppler echocardiographic parameters. Rheumatol Int 28:1239–1243. doi:10.1007/s00296-008-0648-y

    Article  PubMed  Google Scholar 

  128. Simsek I, Koz C, Basar N et al (2011) Mediterranean fever (MEFV) gene mutation frequency is not increased in adults with rheumatic heart disease. Clin Rheumatol 30:491–495. doi:10.1007/s10067-010-1537-9

    Article  PubMed  Google Scholar 

  129. Dabestani A, Noble LM, Child JS et al (1982) Pericardial disease in familial Mediterranean fever. An echocardiographic study. Chest 81:592–595

    Article  CAS  PubMed  Google Scholar 

  130. Tunca M, Akar S, Onen F et al (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine 84:1–11. doi:10.1097/01.md.0000152370.84628.0c

    Article  PubMed  Google Scholar 

  131. Okutur K, Seber S, Oztekin E et al (2008) Recurrent pericarditis as the initial manifestation of familial Mediterranean fever. Med Sci Monit 14:CS139–CS141

    PubMed  Google Scholar 

  132. Brucato A, Shinar Y, Brambilla G et al (2005) Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients. Lupus 14:670–674. doi:10.1191/0961203305lu2197oa

    Article  CAS  PubMed  Google Scholar 

  133. Zimand S, Tauber T, Hegesch T, Aladjem M (1994) Familial Mediterranean fever presenting with massive cardiac tamponade. Clin Exp Rheumatol 12:67–69

    CAS  PubMed  Google Scholar 

  134. Sánchez Ferrer F, Martinez Villar M, Fernández Bernal A et al (2015) Cardiac tamponade as first manifestation in Mediterranean fever with autosomal dominant form. An Pediatr (Barcelona, Spain 2003) 82:e82–e85. doi:10.1016/j.anpedi.2013.11.005

    Article  Google Scholar 

  135. Pamuk BO, Sari I, Selcuk S et al (2013) Evaluation of circulating endothelial biomarkers in familial Mediterranean fever. Rheumatol Int 33:1967–1972. doi:10.1007/s00296-013-2681-8

    Article  CAS  PubMed  Google Scholar 

  136. Girisgen I, Sonmez F, Koseoglu K et al (2012) Polyarteritis nodosa and Henoch–Schonlein purpura nephritis in a child with familial Mediterranean fever: a case report. Rheumatol Int 32:529–533. doi:10.1007/s00296-010-1766-x

    Article  PubMed  Google Scholar 

  137. Wickiser JE, Saulsbury FT (2005) Henoch–Schönlein purpura in a child with hyperimmunoglobulinemia d and periodic fever syndrome. Pediatr Dermatol 22:138–141. doi:10.1111/j.1525-1470.2005.22210.x

    Article  PubMed  Google Scholar 

  138. Still GF (1897) On a form of chronic joint disease in children. Med Chir Trans 80:47–60

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  139. Jamilloux Y, Gerfaud-Valentin M, Henry T, Sève P (2015) Treatment of adult-onset Still’s disease: a review. Ther Clin Risk Manag 11:33–43. doi:10.2147/TCRM.S64951

    CAS  PubMed  Google Scholar 

  140. Rossi-Semerano L, Koné-Paut I (2012) Is Still’s disease an autoinflammatory syndrome? Int J Inflamm. doi:10.1155/2012/480373

    Google Scholar 

  141. Lopalco G, Cantarini L, Vitale A et al (2015) Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives. Mediat Inflamm. doi:10.1155/2015/194864

    Google Scholar 

  142. Gonzalez FA, Beirao P, Adriao J, Coelho ML (2014) Adult-onset Still’s disease presenting as myopericarditis. BMJ Case Rep. doi:10.1136/bcr-2013-202754

  143. Luconi N, Risse J, Busato T et al (2015) Myocarditis in a young man with adult onset Still’s disease successfully treated with Il-1 blocker. Int J Cardiol 189:220–222. doi:10.1016/j.ijcard.2015.04.071

    Article  CAS  PubMed  Google Scholar 

  144. Cavallasca JA, Vigliano CA, Perandones CE, Tate GA (2010) Myocarditis as a form of relapse in two patients with adult Still’s disease. Rheumatol Int 30:1095–1097. doi:10.1007/s00296-009-1031-3

    Article  PubMed  Google Scholar 

  145. Jadhav P, Nanayakkara N (2009) Myocarditis in adult onset Stills disease. Int J Rheum Dis 12:272–274. doi:10.1111/j.1756-185X.2009.01423.x

    Article  PubMed  Google Scholar 

  146. Baratta L, Delfino M, Fiorentini A et al (2004) Alterations of the sympathovagal balance evaluated by heart rate variability in a rare case of adult Still’s disease. Ann Ital Med Int 19:193–197

    PubMed  Google Scholar 

  147. Gupta D, Jagani R, Mendonca S, Rathi KR (2016) Adult-onset Still’s disease with myocarditis and hemophagocytic lymphohistiocytosis: rare manifestation with fatal outcome. Indian J Pathol Microbiol 59:84–86. doi:10.4103/0377-4929.174825

    PubMed  Google Scholar 

  148. Meckenstock R, Therby A, Gibault-Genty G et al (2012) Adult-onset Still’s disease revealed by perimyocarditis and a concomitant reactivation of an EBV infection. BMJ Case Rep. doi:10.1136/bcr.01.2011.3688

  149. Gerfaud-Valentin M, Sève P, Iwaz J et al (2014) Myocarditis in adult-onset Still disease. Medicine (Baltim) 93:280–289. doi:10.1097/MD.0000000000000112

    Article  Google Scholar 

  150. Raffeiner B, Botsios C, Dinarello C et al (2011) Adult-onset Still’s disease with myocarditis successfully treated with the interleukin-1 receptor antagonist anakinra. Jt Bone Spine 78:100–101. doi:10.1016/j.jbspin.2010.09.014

    Article  CAS  Google Scholar 

  151. Yoo WH (2008) Adult onset Still’s disease flared with pericardial effusion. Rheumatol Int 28:285–287. doi:10.1007/s00296-007-0425-3

    Article  CAS  PubMed  Google Scholar 

  152. Buss SJ, Wolf D, Mereles D et al (2010) A rare case of reversible constrictive pericarditis with severe pericardial thickening in a patient with adult onset Still’s disease. Int J Cardiol. doi:10.1016/j.ijcard.2008.12.079

    PubMed  Google Scholar 

  153. Carrilho-Ferreira P, Silva D, Jesus Silva MD et al (2015) Adult-onset Still’s disease and cardiac tamponade: a rare association. Texas Heart Inst J 42:277–280. doi:10.14503/THIJ-14-4101

    Article  Google Scholar 

  154. Lee JS, Do IN, Kang DH et al (2005) Adult onset Still’s disease as a cause of acute severe mitral and aortic regurgitation. Korean J Intern Med 20:264–267

    Article  PubMed  PubMed Central  Google Scholar 

  155. Witkowska AM, Borawska MH (2004) Soluble intercellular adhesion molecule-1 (sICAM-1): an overview. Eur Cytokine Netw 15:91–98

    CAS  PubMed  Google Scholar 

  156. Bongard V, Elias A, Bal dit Sollier C et al (2002) Soluble intercellular adhesion molecule-1 is associated with carotid and femoral atherosclerosis but not with intima-media thickness in a population-based sample. Atherosclerosis 164:297–304

    Article  CAS  PubMed  Google Scholar 

  157. Ridker PM, Hennekens CH, Roitman-Johnson B et al (1998) Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351:88–92. doi:10.1016/S0140-6736(97)09032-6

    Article  CAS  PubMed  Google Scholar 

  158. Morita H, Nishiwaki H, Nagayama Y, Yoshimura A (2009) Portal vein thrombosis in adult-onset Still’s disease: a case report and literature review. Rheumatol Int 29:1515–1518. doi:10.1007/s00296-009-0894-7

    Article  PubMed  Google Scholar 

  159. Siddiqui M, Putman MS, Dua AB (2016) Adult-onset Still’s disease: current challenges and future prospects. Open Access Rheumatol Res Rev. doi:10.2147/OARRR.S83948

    Google Scholar 

  160. Hong D, Yang Z, Han S et al (2014) Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety. Drug Des Dev Ther 8:2345–2357. doi:10.2147/DDDT.S73428

    CAS  Google Scholar 

  161. Ruiz PJ (2007) Cardiac death in a patient with adult-onset Still’s disease treated with the interleukin 1 receptor inhibitor anakinra. Ann Rheum Dis 66:422–423. doi:10.1136/ard.2006.060541

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  162. Inoue N, Shimizu M, Tsunoda S et al (2016) Cytokine profile in adult-onset Still’s disease: comparison with systemic juvenile idiopathic arthritis. Clin Immunol 169:8–13. doi:10.1016/j.clim.2016.05.010

    Article  CAS  PubMed  Google Scholar 

  163. Luthi F, Zufferey P, Hofer MF, So AK (2002) “Adolescent-onset Still’s disease”: characteristics and outcome in comparison with adult-onset Still’s disease. Clin Exp Rheumatol 20:427–430

    CAS  PubMed  Google Scholar 

  164. Raab A, Sengler C, Niewerth M et al (2013) Comorbidity profiles among adult patients with juvenile idiopathic arthritis: results of a biologic register. Clin Exp Rheumatol 31(5):796–802

    PubMed  Google Scholar 

  165. Aizawa-Yashiro T, Oki E, Tsuruga K et al (2012) Intravenous immunoglobulin therapy leading to dramatic improvement in a patient with systemic juvenile idiopathic arthritis and severe pericarditis resistant to steroid pulse therapy. Rheumatol Int 32:1359–1361. doi:10.1007/s00296-010-1413-6

    Article  PubMed  Google Scholar 

  166. Lefèvre-Utile Alain, Galeotti Caroline, Koné-Paut Isabelle (2014) Coronary artery abnormalities in children with systemic-onset juvenile idiopathic arthritis. Jt Bone Spine 81:257–259. doi:10.1016/J.JBSPIN.2013.09.004

    Article  Google Scholar 

  167. Mondal R, Sarkar S, Ghoshal A, Sabui T (2013) Congestive heart failure: an uncommon presentation of systemic onset juvenile idiopathic arthritis (SOJIA). Indian J Pediatr 80:67–69. doi:10.1007/s12098-011-0636-1

    Article  PubMed  Google Scholar 

  168. Sozeri B, Atikan BY, Ozdemir K, Mir S (2016) Assessment of vascular function in systemic onset juvenile idiopathic arthritis. Clin Rheumatol 35:1699–1703. doi:10.1007/s10067-016-3254-5

    Article  PubMed  Google Scholar 

  169. Cantarini L, Lucherini OM, Baldari CT et al (2010) Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome. Clin Exp Rheumatol 28:405–407

    PubMed  Google Scholar 

  170. Cantarini L, Lucherini OM, Brucato A et al (2012) Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. Clin Res Cardiol 101:525–531. doi:10.1007/s00392-012-0422-8

    Article  CAS  PubMed  Google Scholar 

  171. Cantarini L, Lucherini OM, Vitale A et al (2013) Expanding spectrum of TNFRSF1A gene mutations among patients with idiopathic recurrent acute pericarditis. Intern Med J 43:725–727. doi:10.1111/imj.12163

    Article  CAS  PubMed  Google Scholar 

  172. Trost S, Rosé CD (2005) Myocarditis and sacroiliitis: 2 previously unrecognized manifestations of tumor necrosis factor receptor associated periodic syndrome. J Rheumatol 32:175–177

    PubMed  Google Scholar 

  173. Stojanov S, Dejaco C, Lohse P et al (2008) Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. Ann Rheum Dis 67:1292–1298. doi:10.1136/ard.2007.079376

    Article  CAS  PubMed  Google Scholar 

  174. Cantarini L, Lucherini OM, Cimaz R et al (2009) Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome. Int J Immunopathol Pharmacol 22:1051–1058

    Article  CAS  PubMed  Google Scholar 

  175. Carranco-Medina TE, Hidalgo-Calleja C, Calero-Paniagua I et al (2015) Thrombotic manifestations in SAPHO syndrome review of the literature. Reumatol Clin (Engl Ed) 11:108–111. doi:10.1016/j.reumae.2014.07.006

    Article  Google Scholar 

  176. Legoupil N, Révelon G, Allain J et al (2001) Iliac vein thrombosis complicating SAPHO syndrome: MRI and histologic features of soft tissue lesions. Jt Bone Spine 68:79–83

    Article  CAS  Google Scholar 

  177. Coloe J, Diamantis S, Henderson F, Morrell DS (2010) Synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome complicated by seven pulmonary emboli in a 15-year old patient. J Am Acad Dermatol 62:333–336. doi:10.1016/j.jaad.2009.02.049

    Article  PubMed  Google Scholar 

  178. Nishimura T, Kikuta S, Ishihara S, Nakayama S (2017) Heart failure complicating with SAPHO syndrome. BMJ Case Rep 2017:bcr2016218605. doi:10.1136/bcr-2016-218605

    Article  PubMed  Google Scholar 

  179. Endo K, Suzuki A, Sato K, Shiga T (2015) Sudden cardiac arrest secondary to cardiac amyloidosis in a young woman with cryopyrin-associated periodic syndrome. Case Rep 2015:bcr2015209468. doi:10.1136/bcr-2015-209468

    Google Scholar 

  180. Yamamura K, Takada H, Uike K et al (2014) Early progression of atherosclerosis in children with chronic infantile neurological cutaneous and articular syndrome. Rheumatology (Oxford) 53:1783–1787. doi:10.1093/rheumatology/keu180

    Article  CAS  Google Scholar 

  181. Khatibi K, Heit JJ, Telischak NA et al (2016) Cerebral vascular findings in PAPA syndrome: cerebral arterial vasculopathy or vasculitis and a posterior cerebral artery dissecting aneurysm. J Neurointerv Surg 8(8):e29. doi:10.1136/neurintsurg-2015-011753.rep

    Article  PubMed  Google Scholar 

  182. Golia E, Limongelli G, Natale F et al (2014) Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep 16:435. doi:10.1007/s11883-014-0435-z

    Article  PubMed  CAS  Google Scholar 

  183. Ahearn J, Shields KJ, Liu C-C, Manzi S (2015) Cardiovascular disease biomarkers across autoimmune diseases. Clin Immunol 161:59–63. doi:10.1016/j.clim.2015.05.024

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Academic Research Unit, 2nd Department of Internal Medicine, Kepler University Hospital, Med Campus III, Krankenhausstr. 9, 4020, Linz, Austria

    Rainer Hintenberger, Agnes Falkinger, Kathrin Danninger & Herwig Pieringer

  2. Paracelsus Private Medical University Salzburg, Müllner Hauptstraße 48, 5020, Salzburg, Austria

    Herwig Pieringer

Authors
  1. Rainer Hintenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Agnes Falkinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kathrin Danninger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Herwig Pieringer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rainer Hintenberger.

Ethics declarations

Conflict of interest

All authors have no conflict of interest to declare.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 98 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hintenberger, R., Falkinger, A., Danninger, K. et al. Cardiovascular disease in patients with autoinflammatory syndromes. Rheumatol Int 38, 37–50 (2018). https://doi.org/10.1007/s00296-017-3854-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-017-3854-7

Keywords

Search

Navigation